ClinVar Miner

Submissions for variant NM_032043.3(BRIP1):c.1958C>T (p.Ser653Leu)

dbSNP: rs756511744
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000221905 SCV000276992 uncertain significance Hereditary cancer-predisposing syndrome 2021-03-25 criteria provided, single submitter clinical testing The p.S653L variant (also known as c.1958C>T), located in coding exon 13 of the BRIP1 gene, results from a C to T substitution at nucleotide position 1958. The serine at codon 653 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Labcorp Genetics (formerly Invitae), Labcorp RCV000798098 SCV000937695 uncertain significance Familial cancer of breast; Fanconi anemia complementation group J 2023-10-14 criteria provided, single submitter clinical testing This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 653 of the BRIP1 protein (p.Ser653Leu). This variant is present in population databases (rs756511744, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with BRIP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 232772). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt BRIP1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Sema4, Sema4 RCV000221905 SCV002531384 uncertain significance Hereditary cancer-predisposing syndrome 2021-12-22 criteria provided, single submitter curation

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.